[Use of perfluorane in the transfusion therapy of tuberculosis and other bronchopulmonary diseases].
The paper presents the first experience with the Russian blood substitute Perfluorane at pulmonectomy and pleuropulmonectomy in patients with pulmonary tuberculosis. In the patients operated on, the use of PF during simultaneous administration of red blood cells ensures stable hemodynamics, better blood rheological properties and red blood cell metabolic characteristics. Hemostatic events developed in none of 5 cases. PF used in a patient with severe chronic respiratory failures provided a beneficial clinical effect, improved the rheological properties and bioenergy of red blood cells; however, the latter showed an increase in lipid peroxidation.
Zhilin
Iu N
IuN
Bakhmutova
N V
NV
Gamaev
A E
AE
Nabokova
T S
TS
Kaminskaia
G O
GO
Serebriannaia
B A
BA
Gus'kov
M Iu
MIu
D000328:Adult; D001802:Blood Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007432:Intraoperative Period; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D012131:Respiratory Insufficiency / Q000097:blood / Q000628:therapy*; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000628:therapy*
D001802:Blood Substitutes; D005466:Fluorocarbons